CAS 139481-59-7: Candesartán
Descripción:Candesartán es un antagonista del receptor de angiotensina II que se utiliza principalmente en el tratamiento de la hipertensión y la insuficiencia cardíaca. Pertenece a la clase de medicamentos conocidos como sartanes, que actúan bloqueando la acción de la angiotensina II, una hormona que constriñe los vasos sanguíneos y aumenta la presión arterial. La fórmula química de Candesartán es C24H20N6O3, y presenta una estructura de bifenilo con un anillo de tetrazol, lo que contribuye a sus propiedades farmacológicas. Candesartán se administra típicamente en forma oral y es conocido por su larga vida media, lo que permite una dosificación una vez al día. Se absorbe bien en el tracto gastrointestinal, aunque su biodisponibilidad puede verse afectada por la ingesta de alimentos. Los efectos secundarios comunes pueden incluir mareos, fatiga e hipotensión, mientras que los efectos adversos graves pueden involucrar deterioro renal e hiperkalemia. Candesartán está contraindicado en el embarazo debido al posible daño al feto. En general, es un medicamento eficaz para el manejo de la hipertensión y la mejora de los resultados cardiovasculares en pacientes con insuficiencia cardíaca.
Fórmula:C24H20N6O3
InChI:InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)
Clave InChI:InChIKey=HTQMVQVXFRQIKW-UHFFFAOYSA-N
SMILES:O=C(O)C1=CC=CC=2N=C(OCC)N(C21)CC=3C=CC(=CC3)C=4C=CC=CC4C5=NN=NN5
- Sinónimos:
- (1,1'-biphenyl)-4-yl)methyl)-
- (4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- 1-((2′-(1H-Tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid
- 1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
- 1H-Benzimidazole-7-carboxylic acid
- 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- 2-Ethoxy-1-([4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl)-1H-1,3-benzodiazole-7-carboxylic acid
- 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxy
- 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]-7-benzimidazolecarboxylic acid
- Ver más sinónimos
- 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid
- 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylic acid
- 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid
- 2-Ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid
- 2-Ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]-3H-benzoimidazole-4-carboxylic acid
- 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)
- 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benz
- 2-ethoxy-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
- 3-[[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl]-2-ethoxy-3H-benzimidazole-4-carboxylic acid
- Blopress
- Blopress (TN)
- C07468
- Candesartan (USAN)
- Candesartan M1
- Candesartan [USAN:INN]
- Chebi:3347
- Cv 11974
- D00522
- imidazole-7-carboxylic acid
- lic acid
- 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxy
- lic acid
- 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)
- (1,1'-biphenyl)-4-yl)methyl)-
- Candesartan
- 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benz
- imidazole-7-carboxylic acid
- 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)
- (1,1'-biphenyl)-4-yl)methyl)-
- 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benz
- imidazole-7-carboxylic acid
- 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxy
- lic acid
- 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benz
- imidazole-7-carboxylic acid
- 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxy
- lic acid
- 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)
- (1,1'-biphenyl)-4-yl)methyl)-
- 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxy
- lic acid
- 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benz
- imidazole-7-carboxylic acid
- 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)
- (1,1'-biphenyl)-4-yl)methyl)-
- 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)
- (1,1'-biphenyl)-4-yl)methyl)-
- 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benz
- imidazole-7-carboxylic acid
- 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxy
- lic acid
- 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxy
- lic acid
- 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)
- (1,1'-biphenyl)-4-yl)methyl)-
- 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benz
- imidazole-7-carboxylic acid
- 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxy
- lic acid
- 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benz
- imidazole-7-carboxylic acid
- 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)
- (1,1'-biphenyl)-4-yl)methyl)-
- 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benz
- imidazole-7-carboxylic acid
- 2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxy
- lic acid
- 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)
- (1,1'-biphenyl)-4-yl)methyl)-